Financings in Brief: Allegiance
This article was originally published in The Gray Sheet
Executive Summary
Allegiance: Repurchase of up to 3 mil. shares of common stock will take place over the next two years and represent approximately 5% of the firm's 58 mil. outstanding shares. The shares, which will be acquired "on the open market or through privately negotiated transactions," will "be added to Allegiance's treasury shares and used in the administration of the company's employee-stock-purchase plan and other benefit programs," the firm states...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.